Express Healthcare
Home  »  News  »  Coimbatore becomes Metropolis’ eighth lab to get COVID-19 testing approval

Coimbatore becomes Metropolis’ eighth lab to get COVID-19 testing approval

1 1,140
Read Article

Besides the recent addition of Coimbatore, Tamil Nadu, Metropolis has seven other labs in the country that are already approved for COVID-19 testing

With an aim to provide end-to-end testing solutions, Metropolis Healthcare recently began testing for COVID-19 in Tamil Nadu after the lab received the ICMR and NABL approval. The lab has been conducting tests since 10 plus years at its lab in Coimbatore. Additionally, Metropolis has seven other labs in the country that are already approved for COVID-19 testing at Mumbai, Pune, Thane, Chennai, Cochin, Delhi, and Bangalore.

Sharing her views on the same, Dr Anita Suryanaryanan, Vice President, Metropolis Healthcare said, “In addition to Chennai, we are happy to announce that we now have also begun testing for COVID-19 using TrueNat technology at the Coimbatore lab. Metropolis has been at the forefront of this pandemic since day one conducting thousands of tests across our eight COVID capable labs. A warm patient-centric approach, technological superiority, and reliable diagnostic reports have made Metropolis one of the preferred labs which has been further proved in this pandemic.”

RT PCR or reverse transcriptase-polymerase chain reaction is a method that includes capturing specific genes from the extracted RNA from the sample. A small part of specific RNA is converted to DNA, and then it is amplified to a large amount through a series of chemical processes. TrueNat is a chip-based, battery-operated RT-PCR kit. The new TrueNat machines are equipped to detect the E genes and RdRp genes separately from the virus RNA, and hence these tests are treated as a confirmation for the presence of the novel corona virus.

1 Comment
  1. Sathish says

    What’s the cost and how long it will take to get the results.

Leave A Reply

Your email address will not be published.

Attend an exclusive webinar to know more about biomarkers in diagnosis & therapy management of heart failure.
Register Now
close-image
 Introducing Smart Autoinjector: Changing the paradigm of usability, cost & size
Know More?
close-image